Details for Patent: 8,513,262

Summary for Patent: 8,513,262

Title:	Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
Abstract:	A process for the preparation of a compound of formula (I) comprising the steps: (a) reacting a compound of formula (II) wherein L and L′ are suitable leaving groups, with a compound of formula (III) UNH2  (III) to prepare a compound of formula (IV) and subsequently (b) substituting the group R1 by replacement of the leaving group L′.
Inventor(s):	Malcolm Clive Carter, George Stuart Cockerill, Karen Elizabeth Lackey
Assignee:	Novartis AG
Application Number:	US12/691,784
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form;

Drugs Protected by US Patent 8,513,262

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 8,513,262

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9800569	Jan 12, 1998
	99/00048	Jan 08, 1999

International Family Members for US Patent 8,513,262

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1047694		91475	Luxembourg
European Patent Office	1047694		CA 2008 00040	Denmark
European Patent Office	1047694		PA2008012	Lithuania
European Patent Office	1047694		300360	Netherlands
European Patent Office	1047694		PA2008012,C1047694	Lithuania
European Patent Office	1047694		SPC026/2008	Ireland